Management of side effects of novel therapies for multiple myeloma: Consensus statements developed by the International Myeloma Foundation's Nurse Leadership Board Journal Article
| Authors: | Bertolotti, P.; Bilotti, E.; Colson, K.; Curran, K.; Doss, D.; Faiman, B.; Gavino, M.; Jenkins, B.; Lilleby, K.; Love, G.; Mangan, P. A.; Mccullagh, E.; Miceli, T.; Miller, K.; Rogers, K.; Rome, S.; Sandifer, S.; Smith, L. C.; Tariman, J. D.; Westphal, J. |
| Article Title: | Management of side effects of novel therapies for multiple myeloma: Consensus statements developed by the International Myeloma Foundation's Nurse Leadership Board |
| Abstract: | Nurses play an essential role in managing the care of patients with multiple myeloma, who require education and support to receive and adhere to optimal therapy. The International Myeloma Foundation created a Nurse Leadership Board comprised of oncology nurses from leading cancer centers and community practices. An assessment survey identified the need for specific recommendations for managing key side effects of novel antimyeloma agents. Myelosuppression, thromboembolic events, peripheral neuropathy, steroid toxicities, and gastrointestinal side effects were selected for the first consensus statements. The board developed recommendations for healthcare providers in any medical setting, including grading of side-effect toxicity and strategies for managing the side effects in general, with specific recommendations pertaining to the novel agents. |
| Keywords: | dexamethasone; care |
| Journal Title: | Clinical Journal of Oncology Nursing |
| Volume: | 12 |
| Issue: | 3 Suppl. 1 |
| ISSN: | 1092-1095 |
| Publisher: | Oncology Nursing Society (ONS) |
| Date Published: | 2008-06-01 |
| Start Page: | 9 |
| End Page: | 12 |
| Language: | English |
| ACCESSION: | WOS:000256618500002 |
| DOI: | 10.1188/08.cjon.s1.9-12 |
| PROVIDER: | wos |
| PUBMED: | 18490252 |
| PMCID: | PMC4020240 |
| Notes: | --- - Article - S - "Source: Wos" |
